Literature DB >> 19181368

Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.

Arsenio Spinillo1, Barbara Dal Bello, Barbara Gardella, Marianna Roccio, Maria Diletta Dacco', Enrico Maria Silini.   

Abstract

OBJECTIVE: To evaluate the effect of multiple human papillomavirus (HPV) infection on the prevalence of cervical intraepithelial neoplasia (CIN) among women undergoing colposcopy following a cytological diagnosis of atypical squamous cells of undetermined significance (ASCUS) or low grade squamous intraepithelial lesions (LSIL).
METHODS: HPV type-specific sequences of 15 high-risk and 10 low risk types were detected by the line probe, INNO-LiPA HPV genotyping assay before colposcopic examination and targeted biopsies. Multinomial logistic regression was used to evaluate the effect of multiple infection on pathologic outcome adjusting for confounders.
RESULTS: The prevalence of HPV infection in the 1218 women enrolled was 69.9% (851/1218). HPV 16 (37.4%), 31 (26.1%), 51 (17.4%), 52 (15.7%) and 18 (14%) were the commonest viral types identified. Overall, the rates of multiple infection were 22.5% (153/680) among subjects with negative colposcopy/biopsy, 63.6% (218/343) and 79.5% (155/195) among those with CIN 1 and CIN>or=2, respectively (p for trend <.001). The corresponding rates among subjects uninfected by HPV 16 or 18 were 13.5% (77/572), 57.4% (112/195) and 62% (48/77), respectively (p for trend <.001). In multinomial logistic regression, the odds ratio of CIN>or=2 in multiple high risk as compared to single high risk HPV infection was 4.33 (95% confidence intervals=2.32-7.14) in the overall population and 2.76 (95% confidence intervals=1.36-5.59) among women uninfected by HPV 16 or 18.
CONCLUSIONS: Multiple HPV infection is a significant risk factor for CIN>or=2 among women undergoing colposcopy because of ASCUS/LSIL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181368     DOI: 10.1016/j.ygyno.2008.12.037

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

2.  Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.

Authors:  Alexandra Bukowski; Cathrine Hoyo; Michael G Hudgens; Wendy R Brewster; Fidel Valea; Rex C Bentley; Adriana C Vidal; Rachel L Maguire; John W Schmitt; Susan K Murphy; Kari E North; Jennifer S Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-08-02       Impact factor: 4.090

3.  Multiple high-risk HPV genotypes are grouped by type and are associated with viral load and risk factors.

Authors:  L Del Río-Ospina; S C Soto-DE León; M Camargo; R Sánchez; D A Moreno-Pérez; A Pérez-Prados; M E Patarroyo; M A Patarroyo
Journal:  Epidemiol Infect       Date:  2017-02-10       Impact factor: 4.434

4.  Association of low-risk human papillomavirus infection with male circumcision in young men: results from a longitudinal study conducted in Orange Farm (South Africa).

Authors:  Chloé Tarnaud; Pascale Lissouba; Ewalde Cutler; Adrian Puren; Dirk Taljaard; Bertran Auvert
Journal:  Infect Dis Obstet Gynecol       Date:  2011-04-07

5.  Multiple Human Papillomavirus Infections among Chinese Women with and without Cervical Abnormalities: A Population-Based Multi-Center Cross-Sectional Study.

Authors:  Ni Li; Lin Yang; Kai Zhang; Yawei Zhang; Tongzhang Zheng; Min Dai
Journal:  Front Oncol       Date:  2011-10-18       Impact factor: 6.244

6.  Molecular epidemiology and genotype distribution of Human Papillomavirus (HPV) among Arab women in the State of Qatar.

Authors:  Devendra Bansal; Asha A Elmi; Sini Skariah; Pascale Haddad; Laith J Abu-Raddad; Aysha H Al Hamadi; Nady Mohamed-Nady; Nahla M Affifi; Randa Ghedira; Elham Hassen; Asma A J Al-Thani; Afaf A H M Al-Ansari; Ali A Sultan
Journal:  J Transl Med       Date:  2014-11-26       Impact factor: 5.531

7.  Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.

Authors:  Hyun-Woong Cho; Jin Hwa Hong; Kyung Jin Min; Yung-Taek Ouh; Seok Ju Seong; Jun Hye Moon; Seong Hwan Cho; Jae Kwan Lee
Journal:  Cancer Res Treat       Date:  2020-12-24       Impact factor: 4.679

8.  Distribution of Human Papillomavirus Genotypes in Iranian Women According to the Severity of the Cervical Lesion.

Authors:  Mostafa Salehi-Vaziri; Farzin Sadeghi; Firoozeh Sadat Hashemi; Hayedeh Haeri; Farah Bokharaei-Salim; Seyed Hamidreza Monavari; Hossein Keyvani
Journal:  Iran Red Crescent Med J       Date:  2016-01-31       Impact factor: 0.611

9.  Development of a fluorescence-based multiplex genotyping method for simultaneous determination of human papillomavirus infections and viral loads.

Authors:  Zhengrong Sun; Rong Zhang; Zhonghua Liu; Chao Liu; Xiulin Li; Weiqiang Zhou; Lianxia Yang; Qiang Ruan; Xu Zhang
Journal:  BMC Cancer       Date:  2015-11-06       Impact factor: 4.430

10.  HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities.

Authors:  George Krashias; Dana Koptides; Christina Christodoulou
Journal:  BMC Infect Dis       Date:  2017-05-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.